Drappatz J - Search Results

1

Phase II trial of blood-brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma.

Dmello C, Brenner A, Piccioni D, Wen PY, Drappatz J, Mrugala M, Lewis LD, Schiff D, Fadul CE, Chamberlain M, Kesari S, Ahluwalia M, Ghosh D, Sonabend AM, Kumthekar P. Dmello C, et al. Among authors: drappatz j. Neurooncol Adv. 2024 Dec 14;6(1):vdae186. doi: 10.1093/noajnl/vdae186. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 39713041 Free PMC article.

2

Chemotherapy of Oligodendrogliomas.

Drappatz J, Lieberman F. Drappatz J, et al. Prog Neurol Surg. 2018;31:152-161. doi: 10.1159/000467376. Epub 2018 Jan 25. Prog Neurol Surg. 2018. PMID: 29393183

3

The Added Value of Family Caregivers' Level of Mastery in Predicting Survival of Glioblastoma Patients: A Validation Study.

Boele FW, Weimer J, Zamanipoor Najafabadi AH, Murray L, Given CW, Given BA, Donovan HS, Drappatz J, Lieberman FS, Sherwood PR. Boele FW, et al. Among authors: drappatz j. Cancer Nurs. 2022 Sep-Oct 01;45(5):363-368. doi: 10.1097/NCC.0000000000001027. Epub 2021 Sep 30. Cancer Nurs. 2022. PMID: 34608049 Free PMC article.

4

The effects of SmartCare^© on neuro-oncology family caregivers' distress: a randomized controlled trial.

Boele FW, Weimer JM, Marsland AL, Armstrong TS, Given CW, Drappatz J, Donovan HS, Sherwood PR. Boele FW, et al. Among authors: drappatz j. Support Care Cancer. 2022 Mar;30(3):2059-2068. doi: 10.1007/s00520-021-06555-5. Epub 2021 Oct 16. Support Care Cancer. 2022. PMID: 34655326 Free PMC article. Clinical Trial.

5

Non-cytotoxic drugs as potential treatments for gliomas.

Drappatz J, Wen PY. Drappatz J, et al. Curr Opin Neurol. 2004 Dec;17(6):663-73. doi: 10.1097/00019052-200412000-00005. Curr Opin Neurol. 2004. PMID: 15542974 Review.

6

Malignant gliomas: strategies to increase the effectiveness of targeted molecular treatment.

Wen PY, Kesari S, Drappatz J. Wen PY, et al. Among authors: drappatz j. Expert Rev Anticancer Ther. 2006 May;6(5):733-54. doi: 10.1586/14737140.6.5.733. Expert Rev Anticancer Ther. 2006. PMID: 16759164 Review.

7

Medical management of patients with brain tumors.

Wen PY, Schiff D, Kesari S, Drappatz J, Gigas DC, Doherty L. Wen PY, et al. Among authors: drappatz j. J Neurooncol. 2006 Dec;80(3):313-32. doi: 10.1007/s11060-006-9193-2. Epub 2006 Jun 29. J Neurooncol. 2006. PMID: 16807780 Review.

8

Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas.

Doherty L, Gigas DC, Kesari S, Drappatz J, Kim R, Zimmerman J, Ostrowsky L, Wen PY. Doherty L, et al. Among authors: drappatz j. Neurology. 2006 Jul 11;67(1):156-8. doi: 10.1212/01.wnl.0000223844.77636.29. Neurology. 2006. PMID: 16832099 Clinical Trial.

9

Novel therapies for meningiomas.

Wen PY, Drappatz J. Wen PY, et al. Among authors: drappatz j. Expert Rev Neurother. 2006 Oct;6(10):1447-64. doi: 10.1586/14737175.6.10.1447. Expert Rev Neurother. 2006. PMID: 17078786 Review.

10

Chemotherapy and targeted molecular therapies for brain metastases.

Drappatz J, Wen PY. Drappatz J, et al. Expert Rev Neurother. 2006 Oct;6(10):1465-79. doi: 10.1586/14737175.6.10.1465. Expert Rev Neurother. 2006. PMID: 17078787 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters